GO
Loading...

Losing Hope

Monday, 28 Jan 2008 | 6:48 PM ET

Big Pharma's fortunes rise and fall on the ability to sell hope. Hope for an immortal you.

But a study two weeks ago showed that the blockbuster cholesterol pill from Merck and Schering Plough --Vytorin -- is no more effective than a cheaper alternative. So those promises made on TV... well, haven't been kept.

Merck lost one-fifth of its value and Schering-Plough lost a whopping 30% since that report. Three years ago Merck gave investors a similar sinking feeling after withdrawing the wildly popular painkiller Vioxx amid concerns over increased heart risks.

And this isn’t an isolated case. A recent report in the New England Journal of Medicine questions the effectiveness of a dozen leading antidepressants. If the chorus of concern over drugs such as Pfizer's Zoloft and Wyeth's Effexor grows louder, this $21 billion-a-year industry could need triage.

Is there any hope for the stocks that trade on hope?

This is a sector that investors have to trade carefully, says Pete Najarian. But for me the question is -- will doctors continue to prescribe these medicines? I think, yes and sales should continue.

Shares of Merck, Schering Pummeled
Shares of Merck and Schering Plough were pummeled since a study questioned their Vytorin cholesterol pill. The Fast Money traders take a closer look.

This might actually be the time to think about buying Merck, says Guy Adami. I like it at current levels, but I don’t see a need to get into it ahead of earnings.

______________________________________________________
Got something to say? Send us an e-mail at fastmoney-web@cnbc.com and your comment might be posted on the Rapid Recap! Prefer to keep it between us? You can still send questions and comments to fastmoney@cnbc.com.

Trader disclosure: On Jan 28, 2008, the following stocks and commodities mentioned or intended to be mentioned on CNBC’s Fast Money were owned by the Fast Money traders; Macke Owns (YHOO), (EMC); Finerman Owns (GS); Finerman's Firm Owns (AEO), (GLNG), (TSO), (VLO), (YHOO), (WMT); Finerman's Firm Is Short (MDY), (IYR), (IJR), (SPY), (IWM); Finerman's Firm Is Short (LEH) And Owns (LEH) Puts; Najarian Owns (C), (EMC), (MS), (MCD), (MSFT), (BIIB); Najarian Owns (AAPL) Calls, (BBY) Puts, (COP) Calls, (CTSH) Calls, (YHOO) Calls, (YRCW) Calls; Najarian Owns (DOW) Calls; GE Is The Parent Company Of CNBC

  Price   Change %Change
MRK
---
PFE
---

Featured

Contact Fast Money

  • Showtimes

    Halftime Report - Weekdays 12p ET
    Fast Money - Weekdays 5p ET
  • Melissa Lee is the host of CNBC's “Fast Money” and “Options Action.”

  • Scott Wapner is host of the "Fast Money Halftime Report," which airs weekdays from 12 p.m. to 1 p.m. ET.

  • Guy Adami is a contributor on CNBC's "Fast Money." He also is managing director of stockMONSTER.com.

  • Najarian, the "Pit Boss," is cofounder of optionMONSTER.com, a news site for options traders.

  • Finerman is president of Metropolitan Capital Advisors, Inc., a company she co-founded.

  • Founder of EmergingMoney.com

  • Chief Market Strategist for Virtus Investment Partners & CNBC Contributor

Halftime Report